+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Graves Disease Drug"

Graves' Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Graves Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Graves Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Graves Diseases - Pipeline Review, H1 2020 - Product Thumbnail Image

Graves Diseases - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 75 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Graves Disease Drug is a type of drug used to treat Graves Disease, an autoimmune disorder that affects the thyroid. These drugs are typically used to reduce the production of thyroid hormones, which can help reduce the symptoms of Graves Disease. Commonly used drugs include antithyroid medications, such as methimazole and propylthiouracil, as well as beta-blockers, such as propranolol. In some cases, radioactive iodine may be used to reduce the size of the thyroid gland. Graves Disease Drug is part of the larger Immune Disorders Drugs market, which includes drugs used to treat a variety of autoimmune disorders. These drugs are used to reduce inflammation, suppress the immune system, and reduce the production of antibodies. Some companies in the Graves Disease Drug market include AbbVie, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more